EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Marine derived bacteria from restinga ecosystems as a platform for antibiofilm agents and next-generation postbiotics and probiotics (NGPPs)

Leidy J. García Maza, Rafaela Conceição de Souza, Deisiane Fernanda da Rosa, Walter Orlando Beys-da-Silva, Lucélia Santi, Augusto Schrank, Marilene Henning Vainstein, Alexandre José Macedo

Frontiers in Natural Products · 10.07.2026 · 5

DOI: 10.3389/fntpr.2026.1844638 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Natural Products, online erschienen am 10.07.2026. Verfasst von Leidy J. García Maza und 7 weiteren Autor:innen. Die Arbeit nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Marine derived bacteria are a rich source of bioactive compounds that have the potential to be used in the control of infectious diseases and as Next-Generation Postbiotics and Probiotics (NGPPs). However, their antibiofilm activity against major human pathogens remains understudied. This study isolated 211 bacterial strains from Restinga ecosystems along the Southern Coast of Rio Grande do Sul, Brazil and screened them for postbiotics and probiotic traits, such as safety, stress tolerance, and antibiotic susceptibility. A subset of the 65 isolates was used for cultivation of 65 supernatants in mono- and 65 supernatants in co-culture conditions in different media to evaluate antibacterial and antibiofilm activities. About 5%–7% of the supernatants inhibited biofilm formation by at least 50% against Pseudomonas aeruginosa and Staphylococcus aureus. Co-culture enhanced the antibacterial activity against P. aeruginosa . Extraction methods strongly influenced bioactivity outcomes. Conventional extraction yielded antibiofilm activity (40%–80%) against S. aureus , though this was often accompanied by increased planktonic growth. Low or no activity was observed against P. aeruginosa . Notably, solid-phase extraction (SPE) enabled the recovery of highly active fractions. Among the isolates, strain 6, identified as Pseudomonas sputi MaRe06, exhibited the most promising profile by combining strong antibiofilm activity with the most apolar fraction (F100) against S. aureus (80% inhibition at 300 μg/mL) and robust tolerance to in vitro gastrointestinal conditions. These findings highlight the Restinga Ecosystems as a valuable source of bioactive metabolites and support the development of novel antibiofilm agents and NGPPs from marine bacteria.

Zitieren

APA

Maza, L. J. G., Souza, R. C. D., Rosa, D. F. D., Beys-da-Silva, W. O., Santi, L., Schrank, A., Vainstein, M. H., & Macedo, A. J. (2026). Marine derived bacteria from restinga ecosystems as a platform for antibiofilm agents and next-generation postbiotics and probiotics (NGPPs). Frontiers in Natural Products, 5. https://doi.org/10.3389/fntpr.2026.1844638

Vancouver

Maza LJG, Souza RCD, Rosa DFD, Beys-da-Silva WO, Santi L, Schrank A, et al. Marine derived bacteria from restinga ecosystems as a platform for antibiofilm agents and next-generation postbiotics and probiotics (NGPPs). Frontiers in Natural Products. 2026;5. doi:10.3389/fntpr.2026.1844638

BibTeX
@article{Maza2026,
  author = {Maza, Leidy J. García and Souza, Rafaela Conceição de and Rosa, Deisiane Fernanda da and Beys-da-Silva, Walter Orlando and Santi, Lucélia and Schrank, Augusto and Vainstein, Marilene Henning and Macedo, Alexandre José},
  title = {Marine derived bacteria from restinga ecosystems as a platform for antibiofilm agents and next-generation postbiotics and probiotics (NGPPs)},
  journal = {Frontiers in Natural Products},
  year = {2026},
  volume = {5},
  doi = {10.3389/fntpr.2026.1844638}
}
Kostenlos starten →